Jul. 9 at 6:12 PM
$BCTX So the approximate enrollment timeline is:
Date Milestone
Oct 2023 Trial initiated / enrollment began
Early 2024 (estimated) First patients likely enrolled
Apr 2025 >75 patients enrolled
Dec 2025 >160 patients enrolled
May 2026 >230 patients enrolled
For estimating the 144-event interim analysis, the important point is that the earliest patients may have had roughly 2.5–3 years of follow-up by mid/late 2026, while the newest patients may have only months of follow-up. That staggered enrollment is why the exact timing of the 144th death is difficult to predict.....nevertheless 144-event interim analysis will happen in 2026(now to December),reported by company.
